Atea Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 63.17 million compared to USD 35.47 million a year ago. Basic loss per share from continuing operations was USD 0.75 compared to USD 0.43 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.695 USD | -0.14% | -5.91% | +20.00% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.00% | 312M | |
+18.19% | 125B | |
+13.49% | 108B | |
-7.13% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-13.51% | 16.37B | |
+1.13% | 13.58B | |
+27.77% | 11.66B |
- Stock Market
- Equities
- AVIR Stock
- News Atea Pharmaceuticals, Inc.
- Atea Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024